Showing results (1701-1710 of 1,877) with videos related to

Sort By:
Pageof 188
Ecology Letters|June 16, 2023
The ecological causes of functional distinctiveness in communitiesFrançois Munoz, Christopher A Klausmeier, Pierre Gaüzère, et al.
Scientific Reports|April 18, 2020
Hepatocyte-specific deletion of Pparα promotes NAFLD in the context of obesityMarion Régnier, Arnaud Polizzi, Sarra Smati, et al.
Leukemia|January 20, 2009
KIR-ligand incompatibility in the graft-versus-host direction improves outcomes after umbilical cord blood transplantation for acute leukemiaR Willemze, C A Rodrigues, M Labopin, et al.
Msphere|November 8, 2019
Insights into the Host Range, Genetic Diversity, and Geographical Distribution of JingmenvirusesSarah Temmam, Thomas Bigot, Delphine Chrétien, et al.
Antioxidants & Redox Signaling|February 15, 2022
Evidence for Constitutive Microbiota-Dependent Short-Term Control of Food Intake in Mice: Is There a Link with Inflammation, Oxidative Stress, Endotoxemia, and GLP-1?Selma Ben Fradj, Emmanuelle Nédélec, Juliette Salvi, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 27, 2020
HLA-Matched Unrelated Donors for Patients with Sickle Cell Disease: Results of International Donor SearchesKarina Tozatto-Maio, Margareth Afonso Torres, Neifi Hassan Saloum Degaide, et al.
Blood|July 22, 2016
Carfilzomib significantly improves the progression-free survival of high-risk patients in multiple myelomaHervé Avet-Loiseau, Rafael Fonseca, David Siegel, et al.
Frontiers in Plant Science|August 10, 2019
Targeted Capture of Hundreds of Nuclear Genes Unravels Phylogenetic Relationships of the Diverse Neotropical Palm Tribe GeonomateaeOriane Loiseau, Ingrid Olivares, Margot Paris, et al.
British Journal of Haematology|March 28, 2023
Pomalidomide and dexamethasone until progression after first salvage therapy in multiple myelomaLaurent Garderet, Frederique Kuhnowski, Benoit Berge, et al.
Blood|March 23, 2016
Treatment of multiple myeloma with high-risk cytogenetics: a consensus of the International Myeloma Working GroupPieter Sonneveld, Hervé Avet-Loiseau, Sagar Lonial, et al.
Pageof 188